Clostridium Perfringens Type A Vaccine Live Salmonella Vector (Canada)

This page contains information on Clostridium Perfringens Type A Vaccine Live Salmonella Vector for veterinary use.
The information provided typically includes the following:

Clostridium Perfringens Type A Vaccine Live Salmonella Vector Indications
Warnings and cautions for Clostridium Perfringens Type A Vaccine Live Salmonella Vector
Direction and dosage information for Clostridium Perfringens Type A Vaccine Live Salmonella Vector

Clostridium Perfringens Type A Vaccine Live Salmonella Vector

This treatment applies to the following species:

Chickens

Company: Huvepharma Canada

Clostridium Perfringens Type A Vaccine Live Salmonella Vector Indications

This product has been shown to be effective for the vaccination of healthy chickens day of age or older against necrotic enteritis due to Clostridium perfringens type A. Efficacy of the vaccine against Salmonella has not been determined. The duration of immunity has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

STORAGE INSTRUCTIONS: Store at 2-8°C

DOSAGE AND ROUTE OF ADMINISTRATION:

Administer by coarse spray at day of age.

INSTRUCTIONS FOR USE:

Administer by spray at day of age. Reconstitute each vial of product with 5 ml water and dilute with water in an amount sufficient to achieve an applied volume per 100 chickens vaccinated according to the chart below:

Applied Volume	Final Volume (per 10,000 doses)
7 mL	700 mL
10 mL	1000 mL
21 mL	2100 mL
25 mL	2500 mL
30 mL	3000 mL

PRECAUTIONS AND WARNINGS:

● Efficacy of the vaccine against Salmonella has not been determined.

● Inactivate unused contents before disposal.

● Do not mix with other products, except as specified on the label.

● Use entire contents when first opened.

● In case of human exposure, contact a physician.

● Do not accept if the seal is broken.

● Do not vaccinate within 21 days of slaughter.

● Interference of the vaccine with pullorum-typhoid testing has not been assessed and may occur.

ALWAYS READ, UNDERSTAND AND FOLLOW THE LABEL AND USE DIRECTIONS.

Distributed in Canada:

Huvepharma Canada Corp., Inc., 275 Slater Street, Suite 900, Ottawa, Ontario K1P 5H9

Man.:

HUVEPHARMA, INC., LINCOLN, NE USA

VLN/PCN 605/1U11.R1

10 x 10,000 DOSES

10 x 10,000 dose vials/5 ml

CPV007.002

CPN: 1299025.0

HUVEPHARMA CANADA CORPORATION INC.
275 SLATER STREET, SUITE 1800, OTTAWA, ON, K1P 5H9

THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.